ACU333: Prevalence Of Deleterious Oral Habits Among a Group of School Children in Cairo, Egypt: Cross-Sectional Study
Sponsor
Ahram Canadian University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05769166
Collaborator
(none)
1,500
30
Study Details
Study Description
Brief Summary
This study aims to detect the prevalence of practicing oral habits among a group of school children in Cairo, Egypt.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
An online questionnaire utilizing the third domain of Nordic Orofacial Test screen will be distributed among school children (aged five to seven years) parents to measure the prevalence of oral habits.
Study Design
Study Type:
Observational
Anticipated Enrollment
:
1500 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Prevalence Of Deleterious Oral Habits Among a Group of School Children in Cairo, Egypt: Cross-Sectional Study
Anticipated Study Start Date
:
Apr 1, 2023
Anticipated Primary Completion Date
:
May 1, 2023
Anticipated Study Completion Date
:
May 1, 2023
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
School children school children aged from five to seven years |
Other: thired domain of nordic orofcial test-screen
its a questionnaire which the parent will answer
|
Outcome Measures
Primary Outcome Measures
- oral habits (presence / absence) [baseline record]
practicing one or more of the following habit(s): sucking habits, nail biting, bruxism
Eligibility Criteria
Criteria
Ages Eligible for Study:
5 Years
to 7 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
-
school children
-
accept to participate
-
children within the age group
Exclusion Criteria:
- special health care needs children
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Ahram Canadian University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Mennat Allah Ashraf A.Elsabour,
Teaching assistant,
Ahram Canadian University
ClinicalTrials.gov Identifier:
NCT05769166
Other Study ID Numbers:
- ACU 333
First Posted:
Mar 15, 2023
Last Update Posted:
Mar 15, 2023
Last Verified:
Mar 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: